OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11301	Companies
251195	Keywords
180240	Articles
137056	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/16/2025 at 08:30, 1 year 5 months ago

Oxurion annonce la signature de l'accord ferme d'acquisition du français Axiodis CRO, spécialiste français de la biométrie
Oxurion NV acquiert 72% d'Axiodis CRO, une CRO spécialisée en biométrie clinique. Axiodis CRO prévoit un CA de 970K€ en 2025 et vise 2M€ en 2027

Chiffre D'affaires Acquisition Oxurion NV Axiodis CRO Biométrie Clinique
BRIEF

published on 05/15/2025 at 18:05, 1 year 5 months ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Acquisition Actions Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 05/15/2025 at 18:05, 1 year 5 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notifications regarding changes in shareholding percentages to comply with Belgian transparency legislation. Details in attached PDF file

Shareholding Oxurion NV Belgian Legislation Transparency Notifications PDF File
PRESS RELEASE

published on 05/15/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion announces receipt of transparency notifications regarding share ownership by Atlas Special Opportunities II, LLC, crossing thresholds under and above 5% and 25%

Share Ownership Thresholds Oxurion Atlas Special Opportunities II Transparency Notifications
BRIEF

published on 05/12/2025 at 18:05, 1 year 5 months ago

Oxurion Reports Shares Threshold Crossings by Atlas Special Opportunities

Transparency Notification Atlas Special Opportunities Oxurion Shareholding Thresholds Retinal Disease Therapies
BRIEF

published on 05/12/2025 at 18:05, 1 year 5 months ago

Oxurion annonce des franchissements de seuils d'actions par Atlas Special Opportunities

Notification De Transparence Oxurion Opportunités Spéciales Atlas Seuils De Participation Thérapies Contre Les Maladies Rétiniennes
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease

Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelentransacties en voldoet aan Belgische transparantiewetgeving. Het biofarmaceutisch bedrijf ontwikkelt oftalmologische therapieën

Transparantiekennisgevingen Oxurion NV Oftalmologische Therapieën Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf
BRIEF

published on 05/09/2025 at 18:05, 1 year 6 months ago

Oxurion Increases Capital Following Convertible Bond Conversion

Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares

Accesswire

Published on 11/10/2026 at 02:45, 5 hours 20 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 8 hours 55 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 9 hours 5 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 9 hours 33 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 9 hours 50 minutes ago

Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 07:50, 14 minutes ago

From veranda to garden room: enjoy your garden all year round
Published on 11/10/2026 at 07:50, 15 minutes ago

Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Published on 11/10/2026 at 07:45, 19 minutes ago

Telecom Review Group Accelerates the Journey to 10Giga GCC with U6GHz
Published on 11/10/2026 at 07:38, 26 minutes ago

Elmos Semiconductor SE continues profitable growth and strong cash generation in the third quarter of 2026
Published on 11/10/2026 at 07:30, 34 minutes ago

Henkel posts very strong sales growth in the third quarter

Les Echos

Published on 11/10/2026 at 07:00, 1 hour 5 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 1 hour 5 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 13 hours 35 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 13 hours 35 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 14 hours 20 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE